EndoQuest’s ELS robot posted striking early resection results. What will the FDA demand next?
EndoQuest completes PARADIGM enrollment with encouraging preliminary ESD results, setting up a critical FDA De Novo submission.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
What EndoQuest’s PARADIGM Trial approval reveals about robotic ESD innovation in GI surgery
EndoQuest wins FDA approval to complete PARADIGM Trial for its ELS system. Find out what this milestone means for robotic GI surgery innovation.